Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 607-614

  Glanz, Karen ^a,b   Volpicelli, Kathryn ^a   Kanetsky, Peter A ^a   Ming, Michael E ^b   Schuchter, Lynn M ^a   Jepson, Christopher ^b   Domchek, Susan M ^b   Armstrong, Katrina ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MELANOCORTIN 1 RECEPTOR; SUNSCREEN;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HEALTH BELIEF; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; SKIN EXAMINATION; SKIN PROTECTION; SUN EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERVENTION STUDIES; MALE; MELANOMA; MIDDLE AGED; MUTATION; PATIENT COMPLIANCE; PROGNOSIS; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL;

EID: 84876565470     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1174     Document Type: Article

References (25)

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
2. Horner MJ. SEER cancer statistics review, 1975-2007. Bethesda, MD: NIH; 2010.
3. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone A, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:2338-66.
4. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, et al. Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma prone families from three continents. J Med Genet 2007;44:99-106.
5. National Cancer Institute [Internet]. SEER Stat Fact Sheets: melanoma of the skin. [updated 2012 Aug 20; cited 2012 Dec 20]. Available from: http://seer.cancer.gov/statfacts/html/melan.html.
6. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, et al. MC1R variants, melanoma and red hair color phenotype: a metaanalysis. Int J Cancer 2008;122:2753-60. (Pubitemid 351631377)
7. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, et al.MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001;69:765-73. (Pubitemid 32868521)
8. Kanetsky PA, Panossian S, Elder DE, Guerry DP, Ming ME, Schuchter L, et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 2010;116:2416-28.
9. Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK, et al. Melanocortin receptor 1 variants and melanomarisk: A study of 2 European populations. Int J Cancer 2009;125:1868-75.
10. de Snoo FA, Bergman W, Gruis NA. Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer 2003;2: 109-16. (Pubitemid 37247983)
11. HansenCB,Wadge LM,Lowstuter K,Boucher K, Leachman SA. Clinical germline genetic testing for melanoma. Lancet Oncol 2004;5:314-9. (Pubitemid 38541583)
12. Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, et al. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol 2009;61:677.e1-14.
13. Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, et al. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev 2011;20:522-9.
14. Aspinwall LG, Leaf SL, Dola ER, Kohlmann W, Leachman SA. CDKN2A genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev 2008;17:1510-9.
15. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA. Counseling andDNA testing for individuals perceived to be genetically disposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 1999;17:3245-51. (Pubitemid 29470659)
16. Kefford R, Newton Bishop JA, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, et al. Genetic testing for melanoma. Lancet Oncol 2002;3:653-4. (Pubitemid 35314906)
17. Bergenmar M, Hansson J, Brandberg Y. Family members' perceptions of genetic testing for malignant melanoma-A prospective interview study. Eur J Oncol Nurs 2009;13:74-80.
18. GenoMEL - the Melanoma Genetics Consortium [Internet]; [cited 2012 Dec 20]. Available from: http://genomel.org/.
19. Glanz K, Schoenfeld E, Weinstock MA, Layi G, Kidd J, Shigaki DM. Development and reliability of a brief skin cancer risk assessment tool. Cancer Detect Prev 2003;27:311-5. (Pubitemid 36990251)
20. Glanz K, Schoenfeld ER, Steffen A. A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE. Am J Public Health 2010;100:735-41.
21. Nelson D, Kreps G, Hesse B, Croyle R, Willis G, Arora N, et al. The health information national trends survey (HINTS): development, design, and dissemination. J Health Commun 2004;9:443-60. (Pubitemid 39434248)
22. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 1996;69:58-61. (Pubitemid 26083274)
23. Armstrong K, Moye E, Williams S, Berlin J, Reynolds E. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146: 516-26. (Pubitemid 351650561)
24. de Gelder R, van As E, Tilanus-Linthorst M, Bartels C, Boer R, Draisma G, et al. Breast cancer screening: evidence for false reassurance? Int J Cancer 2008;123:680-6. (Pubitemid 351898428)
25. Dorval M, Gauthier G, Maunsell E, Dugas M, Rouleau I, Chiquette J, et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 2005;14:2862-7. (Pubitemid 43068816)